LumiraDx Q2 Adj. EPS $(0.16) Misses $(0.14) Estimate, Sales $21.00M Miss $21.48M Estimate
Portfolio Pulse from Benzinga Newsdesk
LumiraDx reported Q2 adjusted losses of $(0.16) per share, missing the analyst consensus estimate of $(0.14) by 14.29%. The company also reported quarterly sales of $21.00 million, missing the analyst consensus estimate of $21.48 million by 2.22%. This represents a 53.04% decrease over sales of $44.73 million the same period last year.
August 24, 2023 | 11:48 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
LumiraDx's Q2 results missed analyst estimates, with a larger than expected loss per share and lower sales. This could negatively impact the company's stock price in the short term.
LumiraDx's Q2 results were below analyst expectations, with a larger than expected loss per share and lower sales. This negative financial performance could lead to a decrease in the company's stock price in the short term as it indicates the company is not performing as well as expected.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100